JP2023021979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023021979A5 JP2023021979A5 JP2022171607A JP2022171607A JP2023021979A5 JP 2023021979 A5 JP2023021979 A5 JP 2023021979A5 JP 2022171607 A JP2022171607 A JP 2022171607A JP 2022171607 A JP2022171607 A JP 2022171607A JP 2023021979 A5 JP2023021979 A5 JP 2023021979A5
- Authority
- JP
- Japan
- Prior art keywords
- application
- xml
- entirety
- hereby incorporated
- sequence listing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662289671P | 2016-02-01 | 2016-02-01 | |
| US62/289,671 | 2016-02-01 | ||
| JP2018559673A JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087002A Division JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023021979A JP2023021979A (ja) | 2023-02-14 |
| JP2023021979A5 true JP2023021979A5 (enExample) | 2023-04-11 |
Family
ID=59499945
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559673A Pending JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A Active JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2022171607A Pending JP2023021979A (ja) | 2016-02-01 | 2022-10-26 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559673A Pending JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A Active JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20200115372A1 (enExample) |
| EP (1) | EP3411080A4 (enExample) |
| JP (3) | JP2019511562A (enExample) |
| CN (2) | CN108778345B (enExample) |
| AU (1) | AU2017215201B2 (enExample) |
| CA (1) | CA3012700A1 (enExample) |
| IL (2) | IL260859B (enExample) |
| MX (1) | MX2018009325A (enExample) |
| RU (1) | RU2018127537A (enExample) |
| SG (1) | SG11201806544XA (enExample) |
| WO (1) | WO2017136450A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190194150A1 (en) * | 2016-07-01 | 2019-06-27 | Arrakis Therapeutics, Inc. | Compounds and methods for modulating rna function |
| CN111499615B (zh) | 2017-08-04 | 2024-02-02 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| MX2020003695A (es) * | 2017-11-30 | 2020-08-03 | Arrakis Therapeutics Inc | Fotosondas de union a acido nucleico y usos de las mismas. |
| WO2019236644A1 (en) * | 2018-06-05 | 2019-12-12 | Arrakis Therapeutics, Inc. | Encoded libraries and methods of use for screening nucleic acid targets |
| CN109928933B (zh) * | 2019-01-10 | 2021-02-26 | 安徽昊帆生物有限公司 | 2-氯-5-醛基嘧啶及其制备方法 |
| CN114007613A (zh) | 2019-02-05 | 2022-02-01 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| US20220073910A1 (en) * | 2019-02-12 | 2022-03-10 | The Scripps Research Institute | A Cross-Linking Approach to Map Small Molecule-RNA Binding Sites in Cells |
| WO2020264572A1 (en) * | 2019-06-27 | 2020-12-30 | The Scripps Research Institute | Fragment-based screening to identify small molecules that selectively bind rna |
| AU2020377204A1 (en) * | 2019-11-01 | 2022-06-02 | Novartis Ag | The use of a splicing modulator for a treatment slowing progression of huntington's disease |
| GB2591088B (en) * | 2020-01-08 | 2024-07-03 | Adv Med Solutions Ltd | Antimicrobial fibres |
| JP2024542018A (ja) * | 2021-10-28 | 2024-11-13 | アラーキス セラピューティクス， インコーポレイテッド | Ｒｎａ分解剤およびその使用 |
| CN114373522B (zh) * | 2022-01-13 | 2024-09-27 | 腾讯科技（深圳）有限公司 | 分子生成模型的训练方法、装置、设备及存储介质 |
| EP4463188A4 (en) * | 2022-01-14 | 2025-10-22 | Univ Leland Stanford Junior | CHEMICALLY REVERSIBLE 2´-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION |
| JP2025539353A (ja) * | 2022-11-23 | 2025-12-05 | アラーキス セラピューティクス， インコーポレイテッド | Ｒｎａ分解剤およびその使用 |
| CN115850907B (zh) * | 2022-12-29 | 2024-12-17 | 福建泓光半导体材料有限公司 | 一种酚醛树脂组合物及其制备方法和应用以及固化浮雕图案的制备方法 |
| CN119320798A (zh) * | 2023-07-17 | 2025-01-17 | 中国科学院上海营养与健康研究所 | 一种可用于筛选针对rna重复序列药物的报告系统 |
| WO2025024573A1 (en) * | 2023-07-24 | 2025-01-30 | Arrakis Therapeutics, Inc. | Ccr4-not binding rna degraders |
| WO2025137537A1 (en) * | 2023-12-22 | 2025-06-26 | Arrakis Therapeutics, Inc. | Compositions and methods for treating myc-mediated diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6354363A (ja) * | 1986-08-26 | 1988-03-08 | Ss Pharmaceut Co Ltd | キノリン誘導体 |
| US5514786A (en) * | 1990-01-11 | 1996-05-07 | Isis Pharmaceuticals, Inc. | Compositions for inhibiting RNA activity |
| ATE402164T1 (de) * | 2001-04-26 | 2008-08-15 | Eisai R&D Man Co Ltd | Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon |
| ES2668619T3 (es) * | 2007-02-23 | 2018-05-21 | The Research Foundation Of State University Of New York | Compuestos que se dirigen a ARN y procedimientos para prepararlos y usarlos |
| NO2384318T3 (enExample) * | 2008-12-31 | 2018-04-14 | ||
| CN104540525A (zh) * | 2012-07-10 | 2015-04-22 | 贝瑟克里科有限公司 | 大麻素修饰的核酸分子 |
| EP2872474B1 (en) * | 2012-07-10 | 2022-01-19 | Georgia State University Research Foundation, Inc. | Anthraquinone analogs and methods of making and using thereof |
| US8729263B2 (en) * | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| WO2016069922A1 (en) * | 2014-10-29 | 2016-05-06 | Biotium, Inc. | Nucleic acid modifying agents and uses thereof |
-
2017
- 2017-02-01 EP EP17748078.7A patent/EP3411080A4/en not_active Withdrawn
- 2017-02-01 AU AU2017215201A patent/AU2017215201B2/en active Active
- 2017-02-01 MX MX2018009325A patent/MX2018009325A/es unknown
- 2017-02-01 JP JP2018559673A patent/JP2019511562A/ja active Pending
- 2017-02-01 SG SG11201806544XA patent/SG11201806544XA/en unknown
- 2017-02-01 US US16/074,232 patent/US20200115372A1/en not_active Abandoned
- 2017-02-01 CA CA3012700A patent/CA3012700A1/en active Pending
- 2017-02-01 CN CN201780018534.9A patent/CN108778345B/zh active Active
- 2017-02-01 RU RU2018127537A patent/RU2018127537A/ru unknown
- 2017-02-01 WO PCT/US2017/016065 patent/WO2017136450A2/en not_active Ceased
- 2017-02-01 CN CN202211442068.6A patent/CN115721729A/zh active Pending
-
2018
- 2018-07-30 IL IL260859A patent/IL260859B/en active IP Right Grant
-
2021
- 2021-05-24 JP JP2021087002A patent/JP7167248B2/ja active Active
- 2021-06-08 IL IL283799A patent/IL283799B/en unknown
- 2021-12-17 US US17/644,986 patent/US20220281860A1/en not_active Abandoned
-
2022
- 2022-10-26 JP JP2022171607A patent/JP2023021979A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023021979A5 (enExample) | ||
| JP2019502892A5 (enExample) | ||
| CN110352605A (zh) | 一种鉴权算法程序的添加方法、相关设备及系统 | |
| JP2012501504A5 (enExample) | ||
| JP2016523701A5 (enExample) | ||
| BRPI0515554A (pt) | anticorpos anti-ox40l | |
| JP2013517798A5 (enExample) | ||
| JP2018520447A5 (enExample) | ||
| CY1121672T1 (el) | Αντισωματα που προσδενουν τα il-17a και il-17f | |
| JP2019514354A5 (enExample) | ||
| JP2019536800A5 (enExample) | ||
| JP2017505048A5 (enExample) | ||
| JP2015512691A5 (enExample) | ||
| JP2014525291A5 (enExample) | ||
| CN110431585A (zh) | 一种用户画像的生成方法及装置 | |
| JP2012504317A5 (enExample) | ||
| JP2011515029A5 (enExample) | ||
| WO2008001224A3 (en) | Polypeptides from neisseria meningitidis | |
| JP2014509874A5 (enExample) | ||
| JP2014533241A5 (enExample) | ||
| JP2014507581A5 (enExample) | ||
| EA202190438A1 (ru) | Защита цифрового файла от подделки | |
| EP1744277A3 (en) | Electronic image data verification | |
| JP2014508098A5 (enExample) | ||
| JP2014518965A5 (enExample) |